Founder and President @ RXi Pharmaceuticals (fka-ARAIOS/CYTRX LABS)
President and CEO @ Arradial Inc.
Mark Tepper's Education
Columbia University College of Physicians and Surgeons
Ph.D., M.Phil, MA (Biochemistry & Biophysics)
University of Massachusetts Medical School
Postdoctoral Fellow (Molecular Endocrinology)
Clark University
Bachelor of Arts - BA (Chemistry)
Jonathan Dayton HS
Mark Tepper's Skills
Due Diligence
Expert Witness
Start Ups
Licensing
Technology Transfer
Entrepreneurship
R&d
Project Planning
Immunology
Drug Discovery
Mark Tepper's Summary
Mark Tepper, based in Boston, MA, US, is currently a President and CEO at Eumentis Therapeutics Inc., bringing experience from previous roles at Atlantic Aquaculture Technologies, Corbus Pharmaceuticals, Primatope Therapuetics, Inc. and Mass Medical Angels. Mark Tepper holds a Ph.D., M.Phil, MA in Biochemistry & Biophysics @ Columbia University College of Physicians and Surgeons. With a robust skill set that includes Due Diligence, Expert Witness, Start Ups, Licensing, Technology Transfer and more, Mark Tepper contributes valuable insights to the industry. Mark Tepper has 3 emails and 1 mobile phone number on RocketReach.